Editorial Comment to Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
Hiroaki MatsumotoPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)